Pharmacoequity measurement framework: A tool to reduce health disparities [0.03%]
药学公平度测量框架：减少健康差异的工具
Pranav M Patel,Utibe R Essien,Laura Happe
Pranav M Patel
Pharmacoequity is a health system and policy goal of ensuring equitable access to high-quality medications for all individuals, regardless of factors such as race, ethnicity, socioeconomic status, or resource availability to reduce health d...
Brian T Sweet
Brian T Sweet
Getting to specialty treatment in dermatologic inflammatory conditions: Treatment requirements and patient journey [0.03%]
炎症性皮肤病患者治疗需求及就诊现状调查报告
Matthew G Bowles,Autumn D Zuckerman,Josh DeClercq et al.
Matthew G Bowles et al.
Background: Many payers and pharmacy benefit managers (PBMs) use step therapy requirements and formulary alternatives to reduce prescription spending. The clinical utility and ultimate therapy outcomes for patients partic...
Patient characteristics and use for bevacizumab in ophthalmology and oncology in a distributed research network [0.03%]
分布式研究网络中贝伐单抗在眼科和肿瘤科患者特征和使用情况的研究
Jenice S Ko,Aaron B Mendelsohn,Kimberly Daniels et al.
Jenice S Ko et al.
Background: Although bevacizumab and its biosimilars are commonly used, there are limited real-world data on bevacizumab use in the United States, especially biosimilar bevacizumab used in ophthalmologic conditions. ...
Prevalence of obesity-related multimorbidity and its health care costs among adults in the United States [0.03%]
美国成人相关肥胖多重慢性病的患病率及其医疗费用
Kyrian Ezendu,Gerhardt Pohl,Clare J Lee et al.
Kyrian Ezendu et al.
Background: Overweight and obesity are associated with many obesity-related complications (ORCs) and drive increased health care costs. However, data on the impact of obesity severity on multimorbidity and the effect of m...
T Joseph Mattingly nd,Laura E Happe,Laura Cranston
T Joseph Mattingly nd
Background: Over the past 5 years, managed care pharmacy has been shaped by a global pandemic, advancements in generative artificial intelligence (AI), Medicare drug price negotiation policies, and significant therapeutic...
Emerging trends in therapeutics and diagnostics: Perspectives on the 2024 AMCP Foundation Survey [0.03%]
治疗和诊断领域的新兴趋势：2024年AMCP基金会调查展望
Catherine M Lockhart,Michael Manolakis
Catherine M Lockhart
Emerging trends in public policy: Perspectives on the 2024 AMCP Foundation Survey [0.03%]
公共政策中的新兴趋势：2024年AMCP基金会调查的视角
Melissa J Andel,Daniel Tomaszewski
Melissa J Andel
Emerging trends in pharmaceutical payment models: Perspectives on the 2024 AMCP Foundation Survey [0.03%]
2024年AMCP基金会调查中的制药支付模式趋势展望
James T Kenney Jr,Patrick P Gleason
James T Kenney Jr